Axsome Therapeutics
AXSM
AXSM
196 hedge funds and large institutions have $1.97B invested in Axsome Therapeutics in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 67 increasing their positions, 66 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
15% less capital invested
Capital invested by funds: $2.32B → $1.97B (-$351M)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
50% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 42
Holders
196
Holding in Top 10
9
Calls
$79.2M
Puts
$56.9M
Top Buyers
| 1 | +$64.1M | |
| 2 | +$49.4M | |
| 3 | +$38.9M | |
| 4 |
Holocene Advisors
New York
|
+$32.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$32.1M |
Top Sellers
| 1 | -$51.7M | |
| 2 | -$30M | |
| 3 | -$15.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.2M |
| 5 |
Jane Street
New York
|
-$9.51M |